This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Zacks Podcast Highlights: Should Investors Forget the Obamacare Battle and Focus on HealthTech Stocks Instead?
by Eric Dutram
Although changes might be coming to the world of health care, this industry could be the spot for investors to focus on regardless of what Washington decides.
Health Care and Technology: A Perfect Combo for Stock Investors Now?
by Eric Dutram
Although changes might be coming to the world of health care, this industry could be the spot for investors to focus on regardless of what Washington decides.
Are Q1 ETF Toppers Healthy Enough for Further Run in Q2?
by Sanghamitra Saha
Let's do a health check-up for top performing ETFs of Q1 and find out if these can succeed in Q2 too.
Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen
Biotech Bull Making a Comeback
by Kevin Cook
A triple-bottom at $240 was bolstered by the headline capitulation of an infamous Valeant investor
Time to Buy Biotech ETFs?
by Zacks Equity Research
After a painful 2016, biotech stocks are recovering this year. What lies ahead?
Healthcare ETFs in Focus on Obamacare Replacement Plan
by Sweta Killa
House Republicans have released the long-awaited bill to repeal and replace Obama's signature healthcare law last evening. This will unwind much of the law over the next three years.
Trump's Immigration Plans an Overhang on Biotech ETFs?
by Zacks Equity Research
Immigration related uncertainty has put biotech ETFs in focus.
ETF Industry to Get a Product on Marijuana?
by Sanghamitra Saha
A new fund has been filed targeting the medical marijuana industry.
Zacks Market Edge Highlights: Health Care SPDR ETF, iShares NASDAQ Biotechnology ETF, Acadia, Aetna and Gilead
by Zacks Equity Research
Zacks Market Edge Highlights: Health Care SPDR ETF, iShares NASDAQ Biotechnology ETF, Acadia, Aetna and Gilead